N
RBOT

Nuveen’s Vicarious Surgical RBOT Stock Holding History

Nuveen’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,901
Closed -$122K – 3344
2023
Q3 		$122K Sell
6,901
-60
-0.9% -$2.19K ﹤0.01% 3107
2023
Q2 		$382K Buy
6,961
+302
+5% +$19.2K ﹤0.01% 2979
2023
Q1 		$453K Sell
6,659
-89
-1% -$6.92K ﹤0.01% 2831
2022
Q4 		$409K Buy
6,748
+241
+4% +$22.4K ﹤0.01% 2928
2022
Q3 		$654K Sell
6,507
-19
-0.3% -$2.21K ﹤0.01% 2888
2022
Q2 		$576K Buy
+6,526
New +$798K ﹤0.01% 2979

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Nuveen's RBOT Position: Q4 2023 in Review

Nuveen sold out of Vicarious Surgical (RBOT) in Q4 2023, closing a stake of 6,901 shares — an estimated $122K sold.

Nuveen first reported a position in RBOT in Q2 2022 and held it in 6 quarters. The position peaked at $654K in Q3 2022. 72 funds tracked by Wall St. Rank hold RBOT as of Q4 2023.

  • Nuveen reported no remaining Vicarious Surgical position as of Q4 2023 after selling out during the quarter.
  • Nuveen sold 6,901 Vicarious Surgical shares in Q4 2023, an estimated $122K.
  • Nuveen first reported a position in Vicarious Surgical in Q2 2022 and held it in 6 quarters.
  • Nuveen's Vicarious Surgical position peaked at $654K in Q3 2022.
  • 72 funds tracked by Wall St. Rank held Vicarious Surgical as of Q4 2023.

Based on Nuveen's 13F filing for Q4 2023, filed 14 Feb 2024.